Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Icahn School of Medicine at Mount Sinai · Western University · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
702
total citations
- FWCI
- 46.51
- Percentile
- 100%
- References
- 39
Citations per year
Authors
14- BEBruce E. SandsCorresponding
Icahn School of Medicine at Mount Sinai
- BGBrian G. Feagan
Western University, Robarts Clinical Trials
- PRPaul Rutgeerts
KU Leuven
- JCJean‐Frédéric Colombel
Icahn School of Medicine at Mount Sinai, Université Lille Nord de France, Centre Hospitalier Universitaire de Lille
- WJWilliam J. Sandborn
University of California, San Diego
Topics & keywords
Topics
Keywords
- Vedolizumab
- Medicine
- Crohn's disease
- Tumor necrosis factor alpha
- Antagonist
- Internal medicine
- Disease
- Induction therapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.